Table 3.

Multivariate survival analysis of risk factors for prognosis in patients with ovarian cancer.

	B	SE	Wald	P	Exp (B)	95%CI
Clinical grade	0.015	0.248	0.003	0.953	1.015	0.623–1.651
Pathological stage	0.675	0.262	6.669	0.010	1.965	1.177–3.281
Lymph node metastasis	−0.052	0.272	0.036	0.850	0.950	0.577–1.619
Positive expression of HER2	0.594	0.227	6.826	0.009	1.811	1.160–2.827
Positive expression of p-HER2	1.023	0.263	15.094	<0.001	2.781	1.660–4.658
Positive expression of SOCS3	−1.058	0.262	16.295	<0.001	0.347	0.208–0.580
Positive expression of STAT3	0.503	0.229	4.837	0.028	1.654	1.056–2.589
Positive expression of p-STAT3	0.401	0.270	2.197	0.138	1.493	0.879–2.535

Notes: B, the partial regression coefficient; SE, the standard error of the partial regression coefficient; Wald, whether the difference was statistically significant when the overall partial regression coefficient was compared with 0; Exp (B), the relative risk degree; 95%CI, the 95% confidence interval; HER-2, human epidermal growth factor receptor 2; p-HER2, phosphorylated HER2; SOCS3, suppressors of cytokine signaling 3; STAT3, signal transducer and activator of transcription 3; p-STAT3, phosphorylated STAT3.